Related Experiment Videos
Structure of antigen-specific suppressor factors: current views
Survey of Immunologic Research
|January 1, 1982
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Increased urinary free immunoglobulin light chain excretion in patients with multiple sclerosis.
Journal of neuroimmunology·2010
What have we learnt from targeted anti-TNF therapy?
Annals of the rheumatic diseases·2009
[Cellular mechanisms of regulation of the inflammatory response in atherosclerosis: the role of cell contact-mediated signaling].
Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology·2009
[Neonatal Bartter syndrome's special features in very premature newborns].
Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2008
Suppression of tumour necrosis factor production from mononuclear cells by a novel synthetic compound, CLX-090717.
Rheumatology (Oxford, England)·2008
Neutralizing IL-21 and IL-15 inhibits pro-inflammatory cytokine production in rheumatoid arthritis.
Scandinavian journal of immunology·2008
Role of the immune system in the etiology of rheumatic fever.
Survey of immunologic research·1985
Recognition of an Igh-linked histocompatibility antigen, H-40, on B-cell tumors by cytotoxic T lymphocytes.
Survey of immunologic research·1985
Macrophages in the thymus.
Survey of immunologic research·1985
Modulation of immune response in aged humans through different administration modes of thymopentin.
Survey of immunologic research·1985
Confirmative study of the effectiveness of thymopentin in active rheumatoid arthritis.
Survey of immunologic research·1985
Thymopentin in active rheumatoid arthritis. An open, monitored study in 16 patients.
Survey of immunologic research·1985
Dabrafenib-Induced Cutaneous Eruptions in a Patient With Langerhans Cell Histiocytosis.
Case reports in dermatological medicine·2026
Type 1 diabetes mellitus induced by sintilimab: a case report and related case literature analysis.
Frontiers in endocrinology·2026
Lipocalin-2 Emerges as a Core Pathogenic Mediator and Biomarker in Autosomal Dominant Tubulointerstitial Kidney Disease-UMOD via Transcriptomic Profiling.
Kidney diseases (Basel, Switzerland)·2026
Targeting TKT-associated immunometabolic remodeling attenuates experimental lupus nephritis and NET-related inflammation.
Frontiers in cell and developmental biology·2026